DK0598719T3 - Receptorkonjugater til destinering af lægemidler og andre midler - Google Patents

Receptorkonjugater til destinering af lægemidler og andre midler

Info

Publication number
DK0598719T3
DK0598719T3 DK91915386T DK91915386T DK0598719T3 DK 0598719 T3 DK0598719 T3 DK 0598719T3 DK 91915386 T DK91915386 T DK 91915386T DK 91915386 T DK91915386 T DK 91915386T DK 0598719 T3 DK0598719 T3 DK 0598719T3
Authority
DK
Denmark
Prior art keywords
agents
drugs
destination
conjugates
receptor conjugates
Prior art date
Application number
DK91915386T
Other languages
Danish (da)
English (en)
Inventor
Howard C Krivan
Arne Lennart Ingemar Blomberg
Original Assignee
Antex Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antex Biolog Inc filed Critical Antex Biolog Inc
Application granted granted Critical
Publication of DK0598719T3 publication Critical patent/DK0598719T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91915386T 1991-07-31 1991-07-31 Receptorkonjugater til destinering af lægemidler og andre midler DK0598719T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002114629A CA2114629C (en) 1991-07-31 1991-07-31 Receptor conjugates for targeting antibiotics to bacteria
PCT/US1991/005422 WO1993002709A1 (en) 1991-07-31 1991-07-31 Receptor conjugates for targeting drugs and other agents

Publications (1)

Publication Number Publication Date
DK0598719T3 true DK0598719T3 (da) 1999-06-14

Family

ID=25676975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915386T DK0598719T3 (da) 1991-07-31 1991-07-31 Receptorkonjugater til destinering af lægemidler og andre midler

Country Status (8)

Country Link
EP (1) EP0598719B1 (ja)
JP (1) JP3369555B2 (ja)
AT (1) ATE171072T1 (ja)
CA (1) CA2114629C (ja)
DE (1) DE69130235T2 (ja)
DK (1) DK0598719T3 (ja)
ES (1) ES2123514T3 (ja)
WO (1) WO1993002709A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
JPH08133971A (ja) * 1994-09-16 1996-05-28 Toyama Chem Co Ltd 抗ヘリコバクター剤
CA2253204A1 (en) * 1996-05-03 1997-11-13 Roger S. Cubicciotti Prodrug compositions and drug delivery methods using synthetic receptors
JP7534796B2 (ja) * 2019-01-08 2024-08-15 ユニバーシティー オブ ジョージア リサーチ ファウンデーション, インコーポレイテッド 標的化ナノ粒子、及び真菌感染に関連するそれらの使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165238A (en) * 1980-03-12 1984-04-10 Demetrios P. Papahadjopoulos Activated liposomes and method
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
DE3711724A1 (de) * 1987-04-07 1988-10-20 Harro Boerner Medizinische Kom System zum einwirken auf, insbesondere zerstoeren von viren
WO1989001519A1 (en) * 1987-08-20 1989-02-23 Children's Hospital Corporation Human mannose binding protein
CA2017739A1 (en) * 1989-07-18 1991-01-18 Leslie S. Hollis Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
AU6521790A (en) * 1989-10-13 1991-05-16 Hans Schreier Lipophilic acylpyrazinamide prodrugs

Also Published As

Publication number Publication date
JPH06511466A (ja) 1994-12-22
WO1993002709A1 (en) 1993-02-18
DE69130235D1 (de) 1998-10-22
CA2114629C (en) 2003-01-14
EP0598719B1 (en) 1998-09-16
ATE171072T1 (de) 1998-10-15
EP0598719A1 (en) 1994-06-01
ES2123514T3 (es) 1999-01-16
DE69130235T2 (de) 1999-02-11
JP3369555B2 (ja) 2003-01-20
CA2114629A1 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
NO995349L (no) Multivalent vaksinasjonssammensetning med blandet baerer
ES2066603T3 (es) Fungicidas de 3-difluorometilpirazolcarboxamida.
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
UY26380A1 (es) Inhibidores de fab i
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
MX9204132A (es) Composiciones farmaceuticas que contienen rifaximin y procedimiento para su preparacion.
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
DK58291D0 (da) Krystalinsk stof og dets fremstilling
PT100914A (pt) Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
EP0869801A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
DK0598719T3 (da) Receptorkonjugater til destinering af lægemidler og andre midler
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
DE69936052D1 (de) N1 modifizierte glycopeptide
NO307462B1 (no) Imidazopyridin-azolidinoner
ES2115975T3 (es) Derivados de triariletileno utilizados terapeuticamente.
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.